890 related articles for article (PubMed ID: 12037567)
1. Nogo-66 receptor antagonist peptide promotes axonal regeneration.
GrandPré T; Li S; Strittmatter SM
Nature; 2002 May; 417(6888):547-51. PubMed ID: 12037567
[TBL] [Abstract][Full Text] [Related]
2. Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury.
Li S; Strittmatter SM
J Neurosci; 2003 May; 23(10):4219-27. PubMed ID: 12764110
[TBL] [Abstract][Full Text] [Related]
3. Nogo-66 receptor antagonist peptide (NEP1-40) administration promotes functional recovery and axonal growth after lateral funiculus injury in the adult rat.
Cao Y; Shumsky JS; Sabol MA; Kushner RA; Strittmatter S; Hamers FP; Lee DH; Rabacchi SA; Murray M
Neurorehabil Neural Repair; 2008; 22(3):262-78. PubMed ID: 18056009
[TBL] [Abstract][Full Text] [Related]
4. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
Kim JE; Liu BP; Park JH; Strittmatter SM
Neuron; 2004 Oct; 44(3):439-51. PubMed ID: 15504325
[TBL] [Abstract][Full Text] [Related]
5. Immunization with recombinant Nogo-66 receptor (NgR) promotes axonal regeneration and recovery of function after spinal cord injury in rats.
Yu P; Huang L; Zou J; Yu Z; Wang Y; Wang X; Xu L; Liu X; Xu XM; Lu PH
Neurobiol Dis; 2008 Dec; 32(3):535-42. PubMed ID: 18930141
[TBL] [Abstract][Full Text] [Related]
6. Truncated soluble Nogo receptor binds Nogo-66 and blocks inhibition of axon growth by myelin.
Fournier AE; Gould GC; Liu BP; Strittmatter SM
J Neurosci; 2002 Oct; 22(20):8876-83. PubMed ID: 12388594
[TBL] [Abstract][Full Text] [Related]
7. Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor.
Liu BP; Fournier A; GrandPré T; Strittmatter SM
Science; 2002 Aug; 297(5584):1190-3. PubMed ID: 12089450
[TBL] [Abstract][Full Text] [Related]
8. Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury.
Li S; Liu BP; Budel S; Li M; Ji B; Walus L; Li W; Jirik A; Rabacchi S; Choi E; Worley D; Sah DW; Pepinsky B; Lee D; Relton J; Strittmatter SM
J Neurosci; 2004 Nov; 24(46):10511-20. PubMed ID: 15548666
[TBL] [Abstract][Full Text] [Related]
9. The effect of growth factors and soluble Nogo-66 receptor protein on transplanted neural stem/progenitor survival and axonal regeneration after complete transection of rat spinal cord.
Guo X; Zahir T; Mothe A; Shoichet MS; Morshead CM; Katayama Y; Tator CH
Cell Transplant; 2012; 21(6):1177-97. PubMed ID: 22236767
[TBL] [Abstract][Full Text] [Related]
10. Small Nogo-66-binding peptide promotes neurite outgrowth through RhoA inhibition after spinal cord injury.
Deng Q; Cai W; Li S; Zhang Y; Su B
Brain Res Bull; 2013 Oct; 99():140-4. PubMed ID: 24184005
[TBL] [Abstract][Full Text] [Related]
11. Effect of combined treatment with methylprednisolone and soluble Nogo-66 receptor after rat spinal cord injury.
Ji B; Li M; Budel S; Pepinsky RB; Walus L; Engber TM; Strittmatter SM; Relton JK
Eur J Neurosci; 2005 Aug; 22(3):587-94. PubMed ID: 16101740
[TBL] [Abstract][Full Text] [Related]
12. Why do Nogo/Nogo-66 receptor gene knockouts result in inferior regeneration compared to treatment with neutralizing agents?
Teng FY; Tang BL
J Neurochem; 2005 Aug; 94(4):865-74. PubMed ID: 16092935
[TBL] [Abstract][Full Text] [Related]
13. Neuroscience. It takes more than two to Nogo.
Woolf CJ; Bloechlinger S
Science; 2002 Aug; 297(5584):1132-4. PubMed ID: 12183616
[No Abstract] [Full Text] [Related]
14. Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo.
Zheng B; Atwal J; Ho C; Case L; He XL; Garcia KC; Steward O; Tessier-Lavigne M
Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1205-10. PubMed ID: 15647357
[TBL] [Abstract][Full Text] [Related]
15. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth.
Domeniconi M; Cao Z; Spencer T; Sivasankaran R; Wang K; Nikulina E; Kimura N; Cai H; Deng K; Gao Y; He Z; Filbin M
Neuron; 2002 Jul; 35(2):283-90. PubMed ID: 12160746
[TBL] [Abstract][Full Text] [Related]
16. Antibodies neutralizing Nogo-A increase pan-cadherin expression and motor recovery following spinal cord injury in rats.
Atalay B; Bavbek M; Cekinmez M; Ozen O; Nacar A; Karabay G; Gulsen S
Spinal Cord; 2007 Dec; 45(12):780-6. PubMed ID: 17724451
[TBL] [Abstract][Full Text] [Related]
17. A re-assessment of the effects of a Nogo-66 receptor antagonist on regenerative growth of axons and locomotor recovery after spinal cord injury in mice.
Steward O; Sharp K; Yee KM; Hofstadter M
Exp Neurol; 2008 Feb; 209(2):446-68. PubMed ID: 18234196
[TBL] [Abstract][Full Text] [Related]
18. The use of a gold nanoparticle-based adjuvant to improve the therapeutic efficacy of hNgR-Fc protein immunization in spinal cord-injured rats.
Wang YT; Lu XM; Zhu F; Huang P; Yu Y; Zeng L; Long ZY; Wu YM
Biomaterials; 2011 Nov; 32(31):7988-98. PubMed ID: 21784510
[TBL] [Abstract][Full Text] [Related]
19. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth.
Wang KC; Koprivica V; Kim JA; Sivasankaran R; Guo Y; Neve RL; He Z
Nature; 2002 Jun; 417(6892):941-4. PubMed ID: 12068310
[TBL] [Abstract][Full Text] [Related]
20. Comparison of RNAi NgR and NEP1-40 in Acting on Axonal Regeneration After Spinal Cord Injury in Rat Models.
Xu J; He J; He H; Peng R; Xi J
Mol Neurobiol; 2017 Dec; 54(10):8321-8331. PubMed ID: 27921243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
